Cancer Research

Although progress is being made in detecting and understanding many types of cancer and what might cause them, gallbladder cancer remains something of a mystery. 
New research led by two researchers at Roswell Park Comprehensive Cancer Center may lead to using immunotherapy in treating Black women with aggressive breast cancer.
“Sometimes sickness can play life’s roll of film on a fast track. Looking at art, in my opinion, brings that feeling to a halt and helps each frame come alive.”

There’s no question that pancreatic cancer is a challenging disease to treat. National statistics reveal several hard truths: Survival rates remain unacceptably poor.

“Before you begin treatment, you should feel good knowing that you have done your due diligence, you are confident that you have received the correct diagnosis, and you are comfortable with your medical team and your treatment plan,” says Dr. Frederick.
"We hope that we can have an influence on bone pain caused by the myeloma; peripheral neuropathy; and the quality of life of patients, especially those in remission," says Dr. Hillengass.
Researchers at Roswell Park Comprehensive Cancer Center have been actively engaged in the effort to develop treatments or other control strategies that can help communities worldwide to address the impacts of the COVID-19 pandemic.

2020 was shaping up to be a busy and exciting year for Pawel Kalinski, MD, PhD, Vice Chair for Translational Research at Roswell Park, and his team at the Center of Immunology.

Roswell Park’s Christine Ambrosone, PhD, admits she may not have pursued the most conventional route to becoming a leading breast cancer researcher.

“Look what we’ve started. This is so exciting.”

“We have to be really careful about health and diet and exercise, and keeping lean. If glucose can drive cancer growth, then patients with esophageal cancer probably have to be careful about their diet, their glucose intake, and make sure they're speaking to their medical professionals to get advice.”

In 2006, Shinya Yamanaka, a Japanese stem cell researcher, made a groundbreaking discovery that would win him the Nobel Prize. Yamanaka discovered a new way to turn adult, dividing cells into pluripotent stem cells.